Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells
Natural killer (NK) cells provide a vital surveillance against virally infected cells, tumor cells, and antibody-coated cells through the release of cytolytic mediators and gamma interferon (IFN-γ). Hexabromocyclododecane (HBCD) is a brominated flame retardant used primarily in expanded (EPS) and extruded (XPS) polystyrene foams for thermal insulation in the building and construction industry. Tetrabromobisphenol A (TBBPA) is used both as a reactive and an additive flame retardant in a variety of materials. HBCD and TBBPA contaminate the environment and are found in human blood samples. In previous studies, we have shown that other environmental contaminants, such as the dibutyltin (DBT) and tributyltin (TBT), decrease NK lytic function by activating mitogen-activated protein kinases (MAPKs) in the NK cells. HBCD and TBBPA also interfere with NK cell(s) lytic function. The current study evaluates whether HBCD and/or TBBPA have the capacity to activate MAPKs and MAPK kinases (MAP2Ks). The effects of concentrations of HBCD and TBBPA that inhibited lytic function on the phosphorylation state and total levels of the MAPKs (p44/42, p38, and JNK) and the phosphorylation and total levels of the MAP2Ks (MEK1/2 and MKK3/6) were examined. Results indicate that exposure of human NK cells to 10–0.5 μM HBCD or TBBPA activate MAPKs and MAP2Ks. This HBCD and TBBPA-induced activation of MAPKs may leave them unavailable for activation by virally infected or tumor target cells and thus contributes to the observed decreases in lytic function seen in NK cells exposed to HBCD and TBBPA.
KeywordsHexabromocyclododecane MAPK MAP2K MAP3K Tetrabromobisphenol A NK cells
This research was supported by Grant 2T34GM007663-33 and 5U54CA163066-03 from the National Institutes of Health.
Conflict of interest
The authors report no conflicts of interest. The authors are alone responsible for the content and writing of the paper.
- Gain B. Flame retardants’ Albemarle boosts capacity. Chem 1997. Week (July 2, 1997, p. 88). Full text available from PROMT 97:369076.Google Scholar
- Hagmar L, Jakobsson K, Thuresson K, Rylander L, Sjodin A, Bergman A. Computer technicians are occupationally exposed to polybrominated diphenyl ethers and tetrabromobisphenol A. Organohalogen Comp. 2000;47:202–5.Google Scholar
- HSDB (Hazardous Substances Data Bank). 2,2′,6,6′-Tetrabromobisphenol A. Bethesda, MD: National Library of Medicine, 2001. http://www.toxnet.nlm.nih.gov/cgi-bin/sis/search.
- IPCS/WHO (International Program on Chemical Safety/World Health Organization). Environmental Health Criteria 172: tetrabromobisphenol A and derivatives. Geneva: World Health Organization; 1995.Google Scholar
- Lotzova E. Definition and function of natural killer cells. Nat Immunol. 1993;12:177–93.Google Scholar
- Nagayama J, TakasugaT, and Tsuji, H. (Eds.). Contamination levels of brominated flame retardants, dioxins, and organochlorine compounds in the blood of Japanese adults. In: Human Levels and Trends, Part 4, 2001. pp. 218–221. Located at http://www.kemi.se/aktuellt/BFR/bfr_del4.pdf.
- Peterman PH, Orazio CE, Gale RW. Detection of tetrabromobisphenol A and formation of brominated [13C]-bisphenol A’s in commercial drinking water stored in reusable polycarbonate containers. ACS Div Environ Chem Extended Abstr. 2000;40:431–3.Google Scholar
- Ronisz D, Farmen Finne E, Karlsson H, Forlin L. Effects of the brominated flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout. Aquat Toxicol. 2004;69:229–45.PubMedCrossRefGoogle Scholar
- Thomsen C, Froshaug M, Leknes H, Becher G. Brominated flame retardants in breast milk from Norway. Organohalogen Compd. 2003;64:33–6.Google Scholar
- Thomsen C, Froshaug M, Broadwell SI, Becher G, Eggesbo M. Levels of brominated flame retardants in milk from the Norwegian human milk study: HUMIS. Organohalogen Compd. 2005;67:509–12.Google Scholar
- Thornton JW, McCallyM, and Houlihan J. Biomonitoring of industrial pollutants: health and policy implications of the chemical body burden. Public Health Rep. 2002. 117, 315–323. www.ewg.org/reports/bodyburden/findings.php.
- Xu T, Wu X, Chen Q, Zhu S, Liu Y, Pan D, et al. The anti-apoptotic effects of salvianolic acid A on rat cardiomyocytes following ischemia/reperfusion by DUSP-mediated regulation of ERK1/2/JNK pathway. Plos One. 2014;9:1–14.Google Scholar